Scottsdale Facility to Be First in U.S. to Showcase True REST ...( Research Shows Numerous Benefits Incl...),Health

Research Shows Numerous Benefits Including Stress Reduction, Pain Relief and Improved Sleep Patterns

SCOTTSDALE, Ariz., June 16 /PRNewswire/ -- According to the American Medical Association, stress is a factor in more than 75 percent of illness today. The World Health Organization cites stress as America's No. 1 Health Problem. And the American Psychological Association calls stress a "major health problem." An Arizona entrepreneur, however, is launching a business that he hopes will send stress levels tumbling.

This summer, Nick Janicki will open a True REST Float Center in Scottsdale, Ariz. - the first of its kind in the U.S. In the United Kingdom, more than 300 of these types of centers are in operation, with hundreds more throughout Europe. REST stands for Restricted Environmental Stimulus Therapy, a name developed in the late 1970s by Peter Suedfeld and Roderick Borrie for a technique that had previously been called Sensory Deprivation (SD) or Sensory Isolation. The use of sensory restriction as an intervention that alters human consciousness actually began in 1951 at the McGill University Perceptual Isolation Laboratory.

Flotation REST involves floating on top of a pool of saltwater - 10 inches of water and 800 pounds of Epsom salt - in a specially designed tank with minimal light and sound. Because of the high salt content of the water, which is heated to skin surface temperature, a person is able to float effortlessly. The tanks are completely safe and clients of True REST can customize their experience with music and a multitude of light colors for ambiance.

"True REST is a state of complete relaxation," said Janicki. "It's a great way to escape the stresses of everyday life."

Flotation REST has been associated with the following benefits:

    -- Eliminates jet lag
    -- Improves sleep
    -- Quickens rehabilitation and recovery
    -- R
'/>"/>
SOURCE  True REST, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 
Related medicine technology :

1. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
2. Micromet Expands Committed Equity Financing Facility to $75 Million
3. Isogen Launches Major New Facility to Address Global Biopharma Demand
4. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
5. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
6. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
7. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
8. WORLDS First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
9. Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
10. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS